Product
SG2918
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
A Phase I Clinical Study to Evaluate the Safety Tolerability and Preliminary Efficacy of SG2918 in Subjects With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2025-12-28